See more : Portex Minerals Inc. (STACF) Income Statement Analysis – Financial Results
Complete financial analysis of Sunset Capital Assets, Inc. (SNST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sunset Capital Assets, Inc., a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- HV Bancorp, Inc. (HVBC) Income Statement Analysis – Financial Results
- América Móvil, S.A.B. de C.V. (AMOVF) Income Statement Analysis – Financial Results
- Pyramid Technoplast Limited (PYRAMID.BO) Income Statement Analysis – Financial Results
- OPRO CO LTD (228A.T) Income Statement Analysis – Financial Results
- China Foods Holdings Ltd. (CFOO) Income Statement Analysis – Financial Results
Sunset Capital Assets, Inc. (SNST)
About Sunset Capital Assets, Inc.
Aphex BioCleanse Systems, Inc. develops sanitizing solutions without the use of alcohol. It products includes sanitizers, surface disinfectants, wound wash, and solutions for treatment of livestock. The company was incorporated in 2010 and is based in Rochester, New York.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
---|---|---|---|---|---|---|---|---|
Revenue | 12.39K | 399.20K | 1.27M | 431.56K | 280.53K | 306.36K | 291.71K | 468.57K |
Cost of Revenue | 59.51K | 108.38K | 104.03K | 91.71K | 6.91K | 69.34K | 45.55K | 133.06K |
Gross Profit | -47.12K | 290.82K | 1.16M | 339.85K | 273.62K | 237.02K | 246.16K | 335.50K |
Gross Profit Ratio | -380.24% | 72.85% | 91.80% | 78.75% | 97.54% | 77.37% | 84.39% | 71.60% |
Research & Development | -20.36 | -3.41 | 6.05 | -1.41 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | -20.36 | -3.41 | 6.05 | -1.41 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Expenses | 0.00 | -9.04K | 9.08M | -708.08K | -194.81K | -382.65K | -240.95K | -441.77K |
Operating Expenses | 202.40K | 1.64M | 2.57M | 238.68K | 194.81K | 382.65K | 240.95K | 441.77K |
Cost & Expenses | 261.91K | 1.75M | 2.67M | 330.39K | 201.73K | 451.99K | 286.49K | 588.08K |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 2.82K | 7.83K | 417.94K | 708.08K | 598.28K | 4.38K | 6.29K | 13.25K |
Depreciation & Amortization | 59.39K | 1.75M | 2.67M | 330.39K | 161.14K | 52.52K | 22.82K | 3.00 |
EBITDA | -190.13K | -1.28M | -1.39M | 101.17K | 78.81K | -145.63K | 5.22K | -119.52K |
EBITDA Ratio | -1,534.27% | -321.64% | -109.51% | 23.44% | 28.09% | -47.54% | 1.79% | -22.68% |
Operating Income | -249.52K | 67.81K | 15.52K | 101.17K | 78.81K | -145.63K | 5.21K | -106.27K |
Operating Income Ratio | -2,013.53% | 16.99% | 1.22% | 23.44% | 28.09% | -47.54% | 1.79% | -22.68% |
Total Other Income/Expenses | -2.82K | -1.35M | -1.40M | 0.00 | -8.44M | -11.84K | -6.29K | -13.25K |
Income Before Tax | -252.34K | -1.28M | -1.39M | 101.17K | -8.36M | -157.47K | -1.08K | -119.52K |
Income Before Tax Ratio | -2,036.30% | -321.64% | -109.51% | 23.44% | -2,979.15% | -51.40% | -0.37% | -25.51% |
Income Tax Expense | -249.52K | -1.35M | -1.40M | 101.17K | -161.13K | -52.52K | -22.81K | 0.00 |
Net Income | -252.34K | -1.36M | 7.68M | -606.91K | -8.36M | -157.47K | -1.08K | -119.52K |
Net Income Ratio | -2,036.30% | -340.89% | 605.34% | -140.63% | -2,979.15% | -51.40% | -0.37% | -25.51% |
EPS | 0.00 | 266.83M | 246.08M | 17.69M | -0.47 | -0.01 | 0.00 | -0.01 |
EPS Diluted | 0.00 | 266.83M | 7.68M | 17.69M | -0.47 | -0.01 | 0.00 | -0.01 |
Weighted Avg Shares Out | 265.92M | -0.01 | 0.03 | -0.03 | 17.71M | 17.71M | 15.32M | 14.94M |
Weighted Avg Shares Out (Dil) | 265.92M | -0.01 | 0.03 | -0.03 | 17.71M | 17.71M | 15.32M | 14.94M |
Source: https://incomestatements.info
Category: Stock Reports